RAIN
Rain Oncology Inc. Common Stock
RAIN
RAIN
Delisted
RAIN was delisted on the 25th of January, 2024.
38 hedge funds and large institutions have $73.9M invested in Rain Oncology Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.56M | |
| 2 | +$1.13M | |
| 3 | +$765K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$357K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$142K |
Top Sellers
| 1 | -$158K | |
| 2 | -$128K | |
| 3 | -$65.7K | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$62K |
| 5 |
Goldman Sachs
New York
|
-$56K |